Evidence map›Paper›PMID 41071041›Full record

ArticleBioinformatics (Oxford, England)2025

Automating candidate gene prioritization with large language models: from naive scoring to literature-grounded validation.

Taushif Khan, Mohammed Toufiq, Marina Yurieva, Nitaya Indrawattana, Akanitt Jittmittraphap, Nathamon Kosoltanapiwat, Pornpan Pumirat, Passanesh Sukphopetch, Muthita Vanaporn, Karolina Palucka and 3 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Taushif KhanThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, 06032, United States.ORCID 0000-0002-7917-8965
Mohammed ToufiqThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, 06032, United States.
Marina YurievaThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, 06032, United States.
Nitaya IndrawattanaBiomedical Research Incubator Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Akanitt JittmittraphapDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, 73170, Thailand.
Nathamon KosoltanapiwatDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, 73170, Thailand.ORCID 0000-0001-7465-0696
Pornpan PumiratDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, 73170, Thailand.
Passanesh SukphopetchDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, 73170, Thailand.ORCID 0000-0001-5590-0688
Muthita VanapornDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, 73170, Thailand.
Karolina PaluckaThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, 06032, United States.
Basirudeen Syed Ahamed KabeerSidra Medicine, Doha, Qatar.
Darawan RinchaiSt. Jude Children's Research Hospital, Memphis, TN, United States.
Damien ChaussabelThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, 06032, United States.

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Paul Robson · 1985 to 2026
$61.9M
NCI NIH HHS P30 CA034196
6 · The paper itself

Abstract

motivationIdentifying promising therapeutic targets from thousands of genes in transcriptomic studies remains a major bottleneck in biomedical research. While large language models (LLMs) show potential for gene prioritization, they suffer from hallucination and lack systematic validation against expert knowledge.

resultsThe framework identified 609 sepsis-relevant genes with >94% filtering efficiency, demonstrating strong enrichment for inflammatory pathways including TNF-α signaling, complement activation, and interferon responses. Literature validation yielded 30 ultra-high confidence therapeutic candidates, including both established sepsis genes (IL10, TREM1, S100A9, NLRP3) and novel targets warranting investigation. Benchmark validation against expert-curated databases achieved 71.2% recall, with systematic correlation between computational confidence and evidence quality. The final candidate set balanced discovery (11 novel genes) with validation (19 known genes), maintaining biological coherence throughout the filtering process. This framework demonstrates that rigorous methodology can transform unreliable LLM outputs into systematically validated biological insights. By combining computational efficiency with literature grounding, the approach provides a practical tool for prioritizing experimental validation efforts. The modular design enables adaptation to other diseases through knowledge base substitution, offering a systematic approach to literature-guided biomarker discovery. AVAILABILITY AND IMPLEMENTATION: We developed a two-stage computational framework that combines LLM-based screening with literature validation for systematic gene prioritization. Starting with 10 824 genes from the BloodGen3 repertoire, we applied multi-criteria evaluation for sepsis relevance, followed by retrieval-augmented generation using 6346 curated sepsis publications. A novel faithfulness evaluation system verified that LLM predictions aligned with retrieved literature evidence. Source code and implementation details are available at https://github.com/taushifkhan/llm-geneprioritization-framework, vector database at https://doi.org/10.5281/zenodo.15802241, and Interactive demonstration at https://llm-geneprioritization.streamlit.app/.

Indexed as

Computational BiologySepsisDatabases, GeneticGene Expression ProfilingHumansLarge Language Models

Identifiers

PMID41071041
PMCPMC12548045

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.